Skip to main content
Clinical Trials/KCT0008256
KCT0008256
Active, not recruiting
未知

A multicenter retrospective study of the role of adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
290
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 1, 2023
Last Updated
3 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who underwent surgery between 2001\.01\.01 and 2019\.08\.01
  • 2\. All patients who underwent surgery for the treatment of invasive intraductal papillary mucinous tumor
  • 3\. Patients who have been followed up for more than 12 months after surgery
  • 4\. Patients with available imaging, pathological, and surgical data

Exclusion Criteria

  • Patients with distant metastasis or unresectable invasive intraductal papillary mucinous tumor confirmed during surgery (Palliative surgery)

Outcomes

Primary Outcomes

Not specified

Similar Trials